The Incidence of Chronic Limb-Threatening Ischemia in the Midland Region of New Zealand over a 12-Year Period.
arteriosclerosis
chronic limb-threatening ischemia
epidemiology
health services research
incidence
intermittent claudication
peripheral artery disease
Journal
Journal of clinical medicine
ISSN: 2077-0383
Titre abrégé: J Clin Med
Pays: Switzerland
ID NLM: 101606588
Informations de publication
Date de publication:
09 Jun 2022
09 Jun 2022
Historique:
received:
24
05
2022
revised:
05
06
2022
accepted:
07
06
2022
entrez:
24
6
2022
pubmed:
25
6
2022
medline:
25
6
2022
Statut:
epublish
Résumé
The epidemiology of severe PAD, as characterized by short-distance intermittent claudication (IC) and chronic limb-threatening ischemia (CLTI), remains undefined in New Zealand (NZ). This was a retrospective observational cohort study of the Midland region in NZ, including all lower limb PAD-related surgical and percutaneous interventions between the 1st of January 2010 and the 31st of December 2021. Overall, 2541 patients were included. The mean annual incidence of short-distance IC was 15.8 per 100,000, and of CLTI was 36.2 per 100,000 population. The annual incidence of both conditions was greater in men. Women presented 3 years older with PAD (p < 0.001). Patients with short-distance IC had lower ipsilateral major limb amputation at 30 days compared to CLTI (IC 2, 0.3% vs. CLTI 298, 16.7%, p < 0.001). The 30-day mortality was greater in elderly patients (<65 years 2.7% vs. ≥65 years 4.4%, p = 0.049), but did not differ depending on sex (females 36, 3.7% vs. males 64, 4.1%, p = 0.787). Elderly age was associated with a worse survival for both short-distance IC and CLTI. There was a worse survival for females with CLTI. In conclusion, PAD imposes a significant burden in NZ, and further research is required in order to reduce this disparity.
Identifiants
pubmed: 35743374
pii: jcm11123303
doi: 10.3390/jcm11123303
pmc: PMC9225294
pii:
doi:
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : Royal Australasian College of Surgeons
ID : None
Références
Eur J Vasc Endovasc Surg. 2007;33 Suppl 1:S1-75
pubmed: 17140820
Eur Heart J. 2020 May 1;41(17):1636-1649
pubmed: 31883328
J Clin Epidemiol. 1994 Nov;47(11):1237-43
pubmed: 7722559
Lancet Glob Health. 2019 Aug;7(8):e1020-e1030
pubmed: 31303293
Int Angiol. 2018 Aug;37(4):327-334
pubmed: 29936722
BMJ. 2007 Oct 20;335(7624):806-8
pubmed: 17947786
Am J Epidemiol. 2005 Sep 1;162(5):430-7
pubmed: 16076834
J Vasc Surg. 2021 Apr;73(4):1456-1465.e7
pubmed: 33161072
BMJ Open. 2021 Sep 2;11(9):e050833
pubmed: 34475182
Am J Epidemiol. 1994 Sep 1;140(5):418-30
pubmed: 8067334
Circulation. 1990 Dec;82(6):1925-31
pubmed: 2242518
Eur Heart J. 2018 Mar 1;39(9):763-816
pubmed: 28886620
J Rheumatol. 2013 Aug;40(8):1241-3
pubmed: 23908527
Eur Heart J. 2021 Dec 28;43(1):41-43
pubmed: 33742201
JAMA. 2008 Jul 9;300(2):197-208
pubmed: 18612117
J Am Geriatr Soc. 1985 Jan;33(1):13-8
pubmed: 3965550
J Vasc Surg. 2019 Jun;69(6S):3S-125S.e40
pubmed: 31159978
Eur J Vasc Endovasc Surg. 2022 Apr;63(4):602-612
pubmed: 35248439
BMJ Open. 2018 Jan 21;8(1):e018184
pubmed: 29358428
J Vasc Surg. 2014 Sep;60(3):686-95.e2
pubmed: 24820900
Lancet. 2013 Oct 19;382(9901):1329-40
pubmed: 23915883
Br J Surg. 2018 Feb;105(3):252-261
pubmed: 29116654
Med J Aust. 2022 Feb 7;216(2):80-86
pubmed: 34725828
Circulation. 2011 Jul 5;124(1):17-23
pubmed: 21690489
J Vasc Surg. 2013 Apr;57(4 Suppl):18S-26S
pubmed: 23522713
Circ Res. 2015 Apr 24;116(9):1509-26
pubmed: 25908725
Eur J Vasc Endovasc Surg. 2018 Sep;56(3):391-399
pubmed: 29859821
Eur J Vasc Endovasc Surg. 2020 Mar;59(3):437-445
pubmed: 31879146
Circulation. 2021 Aug 31;144(9):e171-e191
pubmed: 34315230
Eur J Vasc Endovasc Surg. 2010 May;39(5):577-85
pubmed: 20303804
Eur J Vasc Endovasc Surg. 2022 May;63(5):714-720
pubmed: 35450775